Mercer Enterprise
Advisory with a Conscience. Strategy with a Mission.
Transformative Advisory for Innovation, Health, and Global Impact
Mercer Enterprise, Inc. delivers executive-level advisory and strategic support to organizations at the intersection of biotechnology, AI, and purpose-driven innovation. We help visionary leaders align mission with execution and unlock long-term value across sectors that matter most.

About Mercer Enterprise
Co-founded by KD Mercer and Daniel Mercer, Mercer Enterprise is a mission-driven advisory firm supporting early-stage ventures, nonprofit-aligned initiatives, and global transformation efforts.
We selectively engage with founders, funders, and public sector teams to help build strategic clarity, operational alignment, and long-term momentum.
Our team brings decades of cross-sector leadership with emphasis in:
– Biotech & medtech strategy
– Artificial intelligence & data innovation
– Digital health, diagnostics, and precision care
– Social impact and philanthropy-centered growth

Vision & Purpose
We envision a world where strategic advisory fuels the success of ventures that solve real problems—climate change, preventable illness, inequality, and more.
Mercer Enterprise exists to serve as a bridge between innovation and impact, combining deep expertise with long-view guidance. We are actively building capacity to:
– Support and collaborate with mission-aligned founders and executives
– Guide initiatives working toward sustainability, global health, and equity
– Expand our support of two emerging foundations focused on neurodiversity and animal welfare
Recent Projects
Our advisory work spans confidential engagements across health tech, public sector modernization, and emerging platforms. Select engagements include:
- Advisory support for a microplastic removal technology platform advancing toward commercialization
- Board advisory for a venture-backed medtech company preparing for scale
- Strategic counsel to an AI company building predictive tools for healthcare and diagnostics
- Panel participation for a biotech startup navigating investor readiness and regulatory pathways
- Board advisory for an early-stage biotech firm focused on Long COVID diagnostics
- Strategic advisory for a carbon reduction initiative with measurable global impact potential
- CxO-level guidance for a B2B healthcare acquisition led by a private equity firm
- Advisory support for a biotech initiative advancing alternatives to animal testing through AI and in vitro modeling
Advisory with a conscience starts here.
Let’s Connect.
Let’s connect.